CClinicalTrials.gg
Not yet recruitingNCT07596368Updated May 19, 2026

THE EFFECT OF MOTIVATIONAL INTERVIEWING ON MENOPAUSE MYTHS AND POSTTRAUMATIC GROWTH IN POSTMENOPAUSAL WOMEN:RANDOMIZED CONTROLLED STUDY

An interventional study of Motivational interviewing in Menopause and Postmenopausal State, sponsored by Inonu University. Not yet recruiting. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-19.

Sponsored by Inonu University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Sex
Female
01

Study summary

This randomized controlled study aims to evaluate the effect of motivational interviewing on menopause myths and posttraumatic growth in postmenopausal women. Participants will be randomly assigned to an intervention group receiving four weekly motivational interviewing sessions or a control group receiving usual care. Outcomes will be assessed before and after the intervention using validated scales.

Read the detailed description

Menopause is a biological transition that may affect women physically, psychologically, and socially. Misconceptions regarding menopause may negatively influence adaptation to this period, while positive coping may support posttraumatic growth.

Motivational interviewing is a client-centered counseling approach designed to strengthen intrinsic motivation and promote positive behavioral change. This randomized controlled trial aims to determine the effect of motivational interviewing on menopause myths and posttraumatic growth in postmenopausal women.

The study will be conducted in Family Health Centers in Gaziantep, Turkey, with 96 postmenopausal women randomly assigned to intervention and control groups. The intervention group will receive four weekly face-to-face motivational interviewing sessions lasting 30-45 minutes. The control group will receive usual care without intervention.

Data will be collected at baseline and after intervention using the Menopause Myths Scale and the Posttraumatic Growth Scale.

02

Conditions studied

  • Menopause
  • Postmenopausal State
03

In context

Lead sponsor

Inonu University is the lead sponsor of 375 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Women who have had their last menstrual period between 12 and 36 months ago,
  • are literate,
  • can read and write in Turkish,
  • do not have any problems that may hinder communication, and
  • do not have any diagnosed psychiatric illness will be included in the study.

Exclusion criteria

Exclusion Criteria:

  • Those receiving HRT treatment,
  • Those whose last menstrual period was 36 months or more ago,
  • Women receiving oncology treatment.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
96 participants (estimated)

Study arms

  • Experimental
    intervention group

    The researcher provided training on motivational interviewing techniques to be applied to the experimental group prior to the intervention. Women were informed about the research, and those wishing to participate were given a voluntary information form to read, and their verbal and written consent was obtained. Before starting the Motivational Interview sessions, the client was informed about the duration, number, and timing of the sessions. Each motivational interview session with the women in the experimental group is planned to last approximately 30-45 minutes. A total of four motivational interview sessions will be conducted with the women in the experimental group, once a week. All sessions will be conducted by inviting the women to their family physician's office. During the motivational interview sessions, counseling will be provided on topics related to the menopausal period, aiming to change negative beliefs about menopause myths and increase post-traumatic growth levels.

    Behavioral: Motivational interviewing

  • No intervention
    control group

    No intervention

Interventions

  • BehavioralMotivational interviewing

    The researcher provided training on motivational interviewing techniques to be applied to the experimental group prior to the intervention. Women will be informed about the research, and those wishing to participate will be given a voluntary information form to read, and their verbal and written consent will be obtained. The client will be informed about the duration, number, and timing of the interviews before the start of the MG sessions. Each motivational interview session with the women in the experimental group is planned to last approximately 30-45 minutes. A total of four MG sessions will be conducted with the women in the experimental group, once a week. All sessions will be conducted by inviting the women to their family physician's office. During the MG sessions, counseling will be provided on topics related to the menopausal period in order to change the women's negative beliefs about menopause myths and to increase their post-traumatic growth levels after menopause.

06

What researchers measure

Primary outcomes

  1. MENOPAUSE MYTHS SCALE

    Women's perceptions of menopause were measured using the Menopause Myths Scale.

    Time frame: At the beginning and at the end of the 4-week intervention period

Secondary outcomes

  1. Post-Traumatic Growth Scale

    The Post-Traumatic Growth Scale was used to assess the extent to which menopause creates trauma in women's lives.

    Time frame: At the beginning and at the end of the 4-week intervention period

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07596368
Lead sponsor
Inonu University
Responsible party
Hilal Alkan (Midwifery Doctoral Student, Inonu University) — Principal investigator
First posted
May 19, 2026
Start date
May 2026 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
May 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion